LivaNova Q4 Adj EPS $0.87 Beats $0.77 Estimate, Sales $310.10M Beat $287.39M Estimate
Portfolio Pulse from Benzinga Newsdesk
LivaNova reported Q4 adjusted EPS of $0.87, surpassing the $0.77 estimate, and sales of $310.10M, exceeding the $287.39M estimate. This represents a 7.41% increase in earnings and a 12.80% increase in sales from the same period last year.
February 21, 2024 | 11:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LivaNova's Q4 earnings and sales exceeded analyst estimates, showing strong year-over-year growth.
Beating both earnings and sales estimates significantly, especially with a double-digit percentage increase from the previous year, is a strong indicator of LivaNova's operational success and could lead to positive investor sentiment and a potential increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100